Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Goujard

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Revue D'Epidemiologie Et De Sante Publique|January 1, 1993
[Growth hormone and Creutzfeldt-Jakob disease]J Goujard
Gynecologie, Obstetrique & Fertilite|June 26, 2004
[Are there any changes in Down Syndrome prevalence in France following the implementation of the measurement of nuchal translucency and maternal serum screening?]J Goujard
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 25, 2000
[Management of risk of fetal exposure to drugs. Historical aspects]J Goujard
Therapie|September 1, 1985
[Drug surveillance. Which methods? For which adverse effects? Application to teratogen monitoring]J Goujard
Acquisitions Medicales Recentes|January 1, 1981
[Estimation of the teratogenic risk associated with the taking of drugs at the beginning of pregnancy]J Goujard
Revue D'Epidemiologie Et De Sante Publique|January 1, 1988
[Research on teratogenic risks using a register of congenital malformations]J Goujard
European Journal of Epidemiology|December 23, 1999
Clusters of birth defects: emergency and management. A review of some publicationsJ Goujard
Revue D'Epidemiologie Et De Sante Publique|January 1, 1994
[Risk related to methodologically disputable studies: the example of vitamin therapy for the prevention of neural tube defects]J Goujard, G Bréart
Revue D'Epidemiologie Et De Sante Publique|January 1, 1994
[Occupational exposure to chemical substances and congenital anomalies: state of the art]S Cordier, J Goujard
Lancet (London, England)|February 26, 1977
First-trimester exposure to progestagen/oestrogen and congenital malformationsJ Goujard, C Rumeau-Rouquette
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Revue D'Epidemiologie Et De Sante Publique|January 1, 1993
[Growth hormone and Creutzfeldt-Jakob disease]J Goujard
Gynecologie, Obstetrique & Fertilite|June 26, 2004
[Are there any changes in Down Syndrome prevalence in France following the implementation of the measurement of nuchal translucency and maternal serum screening?]J Goujard
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 25, 2000
[Management of risk of fetal exposure to drugs. Historical aspects]J Goujard
Therapie|September 1, 1985
[Drug surveillance. Which methods? For which adverse effects? Application to teratogen monitoring]J Goujard
Acquisitions Medicales Recentes|January 1, 1981
[Estimation of the teratogenic risk associated with the taking of drugs at the beginning of pregnancy]J Goujard
Revue D'Epidemiologie Et De Sante Publique|January 1, 1988
[Research on teratogenic risks using a register of congenital malformations]J Goujard
European Journal of Epidemiology|December 23, 1999
Clusters of birth defects: emergency and management. A review of some publicationsJ Goujard
Revue D'Epidemiologie Et De Sante Publique|January 1, 1994
[Risk related to methodologically disputable studies: the example of vitamin therapy for the prevention of neural tube defects]J Goujard, G Bréart
Revue D'Epidemiologie Et De Sante Publique|January 1, 1994
[Occupational exposure to chemical substances and congenital anomalies: state of the art]S Cordier, J Goujard
Lancet (London, England)|February 26, 1977
First-trimester exposure to progestagen/oestrogen and congenital malformationsJ Goujard, C Rumeau-Rouquette
Pageof 8